Luo et al. characterize a comprehensive molecular portrait of neurotransmitter receptor genes across 33 cancer types using multidimensional omics data from The Cancer Genome Atlas and other independent cohorts. They identify clinically relevant neuroregulatory subtypes with distinct molecular features, advancing the emerging field of cancer neuroscience.